Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 217 institutions that hold shares in the stock, with a total of 116 Million shares, which have been reported (via 13F filing form) to have a value of $1.09 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
May 15, 2025 Q1 2025 |
329,262
shares
|
$3.1 Million
0.91% of portfolio
|
Q1 2025
Added 39.36%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
317,664
shares
|
$2.99 Million
0.0% of portfolio
|
Q4 2024
Reduced 77.66%
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
314,586
shares
|
$2.96 Million
0.01% of portfolio
|
Q1 2025
Added 1119.18%
|
|
Frontier Capital Management CO LLC
|
May 15, 2025 Q1 2025 |
289,603
shares
|
$2.72 Million
0.04% of portfolio
|
Q1 2025
Reduced 2.83%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
287,653
shares
|
$2.7 Million
0.0% of portfolio
|
Q1 2025
Added 115.03%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
269,976
shares
|
$2.54 Million
0.0% of portfolio
|
Q1 2025
Added 120.14%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
266,404
shares
|
$2.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.62%
|
|
Exome Asset Management LLC
New York, NY |
May 15, 2025 Q1 2025 |
258,391
shares
|
$2.43 Million
2.4% of portfolio
|
Q1 2025
New holding
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
251,817
shares
|
$2.37 Million
0.01% of portfolio
|
Q1 2025
Added 33.48%
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
242,825
shares
|
$2.28 Million
0.0% of portfolio
|
Q1 2025
Added 65.18%
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
231,224
shares
|
$2.17 Million
0.0% of portfolio
|
Q1 2025
Added 20.28%
|
|
Pdt Partners, LLC
New York, NY |
May 15, 2025 Q1 2025 |
224,176
shares
|
$2.11 Million
0.18% of portfolio
|
Q1 2025
New holding
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
223,215
shares
|
$2.1 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
206,965
shares
|
$1.95 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.77%
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
194,955
shares
|
$1.83 Million
0.0% of portfolio
|
Q1 2025
Added 36.41%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
167,625
shares
|
$1.58 Million
0.0% of portfolio
|
Q1 2025
Added 9.4%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
157,791
shares
|
$1.48 Million
0.0% of portfolio
|
Q1 2025
Added 10.06%
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
154,634
shares
|
$1.45 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
154,354
shares
|
$1.45 Million
0.0% of portfolio
|
Q1 2025
Added 94.12%
|
|
Rafferty Asset Management, LLC
New York, NY |
May 14, 2025 Q1 2025 |
147,353
shares
|
$1.39 Million
0.01% of portfolio
|
Q1 2025
Reduced 12.02%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
146,294
shares
|
$1.38 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
137,751
shares
|
$1.29 Million
0.42% of portfolio
|
Q3 2023
Reduced 54.2%
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
133,627
shares
|
$1.26 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.03%
|
|
Summit Tx Capital, L.P.
Fort Worth, TX |
May 15, 2025 Q1 2025 |
129,858
shares
|
$1.22 Million
0.06% of portfolio
|
Q1 2025
New holding
|
|
Exodus Point Capital Management, LP
New York, NY |
May 14, 2025 Q1 2025 |
118,869
shares
|
$1.12 Million
0.01% of portfolio
|
Q1 2025
New holding
|